These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24841163)

  • 41. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
    Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
    J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception.
    Leidy NK; Gutierrez B; Lampl K; Uryniak T; O'Brien CD
    J Asthma; 2009 Dec; 46(10):1006-12. PubMed ID: 19995138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
    Corren J; Berkowitz R; Murray JJ; Prenner B
    Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Hozawa M
    Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma.
    Langdon CG; Adler M; Mehra S; Alexander M; Drollmann A
    Respir Med; 2005 Oct; 99(10):1275-85. PubMed ID: 16024244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
    Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
    Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma.
    Tashkin DP; Moore GE; Trudo F; DePietro M; Chipps BE
    J Allergy Clin Immunol Pract; 2016; 4(4):705-12. PubMed ID: 27039236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group.
    Faurschou P; Steffensen I; Jacques L
    Eur Respir J; 1996 Sep; 9(9):1885-90. PubMed ID: 8880107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
    Chauhan BF; Jeyaraman MM; Singh Mann A; Lys J; Abou-Setta AM; Zarychanski R; Ducharme FM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010347. PubMed ID: 28301050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol.
    Matsunaga K; Kawabata H; Hirano T; Sugiura H; Minakata Y; Ichinose M
    Pulm Pharmacol Ther; 2013 Apr; 26(2):189-94. PubMed ID: 23123925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
    Murphy KR; Dhand R; Trudo F; Uryniak T; Aggarwal A; Eckerwall G
    Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
    Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
    Worth H; Muir JF; Pieters WR
    Respiration; 2001; 68(5):517-26. PubMed ID: 11694816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
    Vermeulen JH; Gyurkovits K; Rauer H; Engelstätter R
    Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.